Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver D Howes

Showing results (261-270 of 329) with videos related to

Pageof 33
Sort By:
Molecular Imaging|March 18, 2025
Effect of the TAAR1 Partial Agonist Ralmitaront on Presynaptic Dopamine Synthesis Capacity Measured Using [<sup>18</sup>F]DOPA PET in Naïve and Cocaine-Treated MiceDavid R Bonsall, Michelle Kokkinou, Els F Halff, et al.
Frontiers in Psychiatry|March 27, 2023
Parsing neurobiological heterogeneity of the clinical high-risk state for psychosis: A pseudo-continuous arterial spin labelling studyDominic Oliver, Cathy Davies, Fernando Zelaya, et al.
Molecular Imaging|February 1, 2023
Evaluation of Intraperitoneal [<sup>18</sup>F]-FDOPA Administration for Micro-PET Imaging in Mice and Assessment of the Effect of Subchronic Ketamine Dosing on Dopamine Synthesis CapacityEls F Halff, Sridhar Natesan, David R Bonsall, et al.
Nature Communications|February 21, 2025
Striatal dopamine D2/D3 receptor regulation of human reward processing and behaviourMartin Osugo, Matthew B Wall, Pierluigi Selvaggi, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 15, 2018
Prefrontal GABA levels, hippocampal resting perfusion and the risk of psychosisGemma Modinos, Fatma Şimşek, Matilda Azis, et al.
Imaging Neuroscience (Cambridge, Mass.)|February 24, 2025
The relationship between SV2A levels, neural activity, and cognitive function in healthy humans: A [11C]UCB-J PET and fMRI studyEkaterina Shatalina, Ellis Chika Onwordi, Thomas Whitehurst, et al.
BMJ Open|November 26, 2021
Cross-sectional study comparing cognitive function in treatment responsive versus treatment non-responsive schizophrenia: evidence from the STRATA studyEdward Millgate, Eugenia Kravariti, Alice Egerton, et al.
The Lancet. Psychiatry|July 5, 2025
Absolute neutrophil count and adverse drug reaction monitoring during clozapine treatment: consensus guidelines from a global Delphi panelDan Siskind, Korinne Northwood, Toby Pillinger, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 4, 2018
Correction: Prefrontal GABA levels, hippocampal resting perfusion and the risk of psychosisGemma Modinos, Fatma Şimşek, Matilda Azis, et al.
Translational Psychiatry|August 13, 2021
N-methyl-D-aspartate receptor availability in first-episode psychosis: a PET-MR brain imaging studyKatherine Beck, Atheeshaan Arumuham, Mattia Veronese, et al.
Pageof 33

Showing results (261-270 of 329) with videos related to

Sort By:
Pageof 33
Molecular Imaging|March 18, 2025
Effect of the TAAR1 Partial Agonist Ralmitaront on Presynaptic Dopamine Synthesis Capacity Measured Using [<sup>18</sup>F]DOPA PET in Naïve and Cocaine-Treated MiceDavid R Bonsall, Michelle Kokkinou, Els F Halff, et al.
Frontiers in Psychiatry|March 27, 2023
Parsing neurobiological heterogeneity of the clinical high-risk state for psychosis: A pseudo-continuous arterial spin labelling studyDominic Oliver, Cathy Davies, Fernando Zelaya, et al.
Molecular Imaging|February 1, 2023
Evaluation of Intraperitoneal [<sup>18</sup>F]-FDOPA Administration for Micro-PET Imaging in Mice and Assessment of the Effect of Subchronic Ketamine Dosing on Dopamine Synthesis CapacityEls F Halff, Sridhar Natesan, David R Bonsall, et al.
Nature Communications|February 21, 2025
Striatal dopamine D2/D3 receptor regulation of human reward processing and behaviourMartin Osugo, Matthew B Wall, Pierluigi Selvaggi, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 15, 2018
Prefrontal GABA levels, hippocampal resting perfusion and the risk of psychosisGemma Modinos, Fatma Şimşek, Matilda Azis, et al.
Imaging Neuroscience (Cambridge, Mass.)|February 24, 2025
The relationship between SV2A levels, neural activity, and cognitive function in healthy humans: A [11C]UCB-J PET and fMRI studyEkaterina Shatalina, Ellis Chika Onwordi, Thomas Whitehurst, et al.
BMJ Open|November 26, 2021
Cross-sectional study comparing cognitive function in treatment responsive versus treatment non-responsive schizophrenia: evidence from the STRATA studyEdward Millgate, Eugenia Kravariti, Alice Egerton, et al.
The Lancet. Psychiatry|July 5, 2025
Absolute neutrophil count and adverse drug reaction monitoring during clozapine treatment: consensus guidelines from a global Delphi panelDan Siskind, Korinne Northwood, Toby Pillinger, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 4, 2018
Correction: Prefrontal GABA levels, hippocampal resting perfusion and the risk of psychosisGemma Modinos, Fatma Şimşek, Matilda Azis, et al.
Translational Psychiatry|August 13, 2021
N-methyl-D-aspartate receptor availability in first-episode psychosis: a PET-MR brain imaging studyKatherine Beck, Atheeshaan Arumuham, Mattia Veronese, et al.
Pageof 33